Federal regulators last Friday finalized a highly anticipated rule for the Medicaid Drug Rebate Program (MDRP) with new identifiers and [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Delaware Gov. John Carney (D) late last week signed into law a bill to prohibit “discrimination against 340B entities by [...] …
A major drug industry trade group and the federal government have asked a federal judge to continue to pause litigation [...] …
An influential Republican senator this morning requested detailed information from Eli Lilly and Amgen on their 340B programs, including the [...] …
The federal government’s recent threat to penalize Johnson & Johnson (J&J) for its unapproved 340B rebate model could spark a [...] …
A federal district judge ruled that four drugmakers’ 340B contract pharmacy restrictions—as implemented in 2021—do not violate the 340B statute, [...] …
The federal agency that oversees the 340B program today formally warned Johnson & Johnson (J&J) that it must “cease implementation [...] …
A Washington, D.C.-based children’s hospital has sued the federal government for authorizing drugmaker Johnson & Johnson (J&J) to perform “unlawful” [...] …
Four diabetes drugmakers are urging a federal appeals court to uphold a lower court’s decision to dismiss 340B antitrust claims [...] …
The federal government is likely to continue opposing 340B rebate models even as it moves to resolve four separate contract [...] …